JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,844 | +22.6% | 30,540 | +44.4% | 0.00% | – |
| Q2 2023 | $251,016 | -12.6% | 21,147 | -10.9% | 0.00% | – |
| Q1 2023 | $287,217 | +17.9% | 23,737 | +28.3% | 0.00% | – |
| Q4 2022 | $243,618 | +18.3% | 18,498 | +22.0% | 0.00% | – |
| Q3 2022 | $206,000 | -34.0% | 15,157 | -40.6% | 0.00% | – |
| Q2 2022 | $312,000 | -47.1% | 25,518 | -38.0% | 0.00% | – |
| Q1 2022 | $590,000 | +293.3% | 41,159 | +439.2% | 0.00% | – |
| Q4 2021 | $150,000 | +138.1% | 7,634 | +159.4% | 0.00% | – |
| Q3 2021 | $63,000 | +21.2% | 2,943 | +43.7% | 0.00% | – |
| Q2 2021 | $52,000 | – | 2,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |